Adam Hines, MD
Sports Medicine · Allen, TXNPI 1053606210
Payments from drug & device makers
What this record shows
This record is dominated by grants: $23,750 of the $39,003 with a category attached, or 60.9%. Arthrex accounts for 63.4% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2020 at $23,594 and has fallen 98.4% since, to $368 in 2025. Among sports medicine clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 113 payments — averaging $345.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$25K
- Smith+Nephew$6K
- DJO, LLC$4K
- Peerless Surgical Inc.$2K
- Stryker$580
- Medacta USA, Inc.$348
- plus $2K from 13 others
What the payments were for
- Grants$23,75061%
- Travel & lodging$1,7124%
- Food & beverage$3,2798%
- Education$10,26326%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 43 | $24,718 |
| Smith+Nephew | 9 | $5,513 |
| DJO, LLC | 4 | $3,750 |
| Peerless Surgical Inc. | 3 | $2,474 |
| Stryker | 13 | $580 |
| Medacta USA, Inc. | 3 | $348 |
| Johnson & Johnson(2 entities) | 11 | $285 |
| Vericel Corporation | 6 | $252 |
| Pylant Medical | 3 | $248 |
| Zimmer Biomet | 3 | $223 |
| Biom'up France SAS | 2 | $162 |
| Innovation Technologies Inc | 3 | $143 |
| International Life Sciences | 1 | $98 |
| Ferring Pharmaceuticals Inc. | 4 | $86 |
| Abbott | 1 | $32 |
| Avanos Medical | 1 | $23 |
| Bioventus LLC | 1 | $23 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| Pacira Therapeutics, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REVERSE SHOULDER$253
- HemoBlast Bellows$147
- Quatro X$129
- MACI$124
- Irrisept$100
How this compares
$39,003 in reported general payments places this provider in the 90th percentile of 437 sports medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 24 | $313 |
| Ondansetron OdtOndansetron | 27 | $141 |
| Gabapentin | 18 | $56 |
| Oxycodone Hcl | 14 | $49 |
| Tramadol Hcl | 12 | $31 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Allen
- Jeffrey LueAllen$53K
- Thomas DeberardinoSan Antonio$3.5M
- Robert ScheinbergDallas$2.2M
- Walter LoweHouston$1.4M
- Reed BartzSunnyvale$1.2M
- James GregoryHouston$565K
- John McDonaldAustin$499K
- James McKinleyTyler$305K
- Kelechi OkorohaDallas$297K
- Leon PaulosPearland$289K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.